| Baseline | After 8 weeks of ingestion | Standard value | ||
TSE | Placebo | TSE | Placebo |
| |
Red blood cells (×104 cells/µL) | 430 ± 30 | 446 ± 38 | 431 ± 35 | 447 ± 37 | 380 - 500 |
Leukocytes (cells/µL) | 5333 ± 1333 | 5055 ± 1371 | 4765 ± 1252 | 5059 ± 1452 | 3300 - 9000 |
Hemoglobin (g/dL) | 13.0 ± 1.1 | 13.4 ± 0.9 | 13.4 ± 1.1 | 13.6 ± 0.8 | 11.5 - 15.0 |
Hematocrit (%) | 41.7 ± 2.8 | 42.7 ± 2.6 | 41.7 ± 2.9 | 42.7 ± 2.5 | 34.8 - 45.0 |
Platelets (×104 cells/µL) | 31.3 ± 5.4 | 27.4 ± 5.0 | 29.4 ± 5.0 | 27.0 ± 5.2 | 14.0 - 34.0 |
Neutrophils (cells/µL) | 3152 ± 1091 | 2927 ± 929 | 2731 ± 1026 | 2929 ± 940 |
|
Lymphocytes (cells/µL) | 1783 ± 604 | 1738 ± 586 | 1620 ± 457 | 1697 ± 560 |
|
Monocytes (cells/µL) | 254 ± 88 | 234 ± 67 | 260 ± 77 | 264 ± 78 |
|
Eosinophils (cells/µL) | 111 ± 93 | 121 ± 78 | 114 ± 55 | 125 ± 66 |
|
Basophils (cells/µL) | 32.6 ± 14.5 | 34.5 ± 18.9 | 39.5 ± 17.0 | 44.9 ± 12.4 |
|